Reviving the Dead
De-Extinction’s High-Stakes Gamble on Earth’s Future
The birth of three wolf pups in April 2025 didn’t look like much at first—fuzzy, squirming bundles named Romulus, Remus, and Khaleesi. But these weren’t ordinary wolves. Colossal Biosciences, the Dallas-based biotech juggernaut, had edited 14 genes in gray wolf cells to resurrect traits from the dire wolf, extinct for over 10,000 years. It was a milesto…
